Advertisement

Topics

STAT Plus: Pharmalittle: A generic rival for opioid treatment & an oncology setback for J&J

09:24 EDT 1 Sep 2017 | STAT

Indivior saw its stock price plummet after a U.S. court ruling opened the door to a generic rival to Suboxone, its treatment for opioid addiction.

Original Article: STAT Plus: Pharmalittle: A generic rival for opioid treatment & an oncology setback for J&J

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Pharmalittle: A generic rival for opioid treatment & an oncology setback for J&J"

Quick Search
Advertisement
 

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...